Rui Li

12PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsPrimary health careHaematologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 24, 2026
Incidence of clinically significant chemotherapy induced nausea and vomiting with brentuximab vedotin and AVD in comparison with ABVD using standard anti-emetic prophylaxis.

|Jul 03, 2026
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.

|Jun 25, 2026
Embedding a primary care provider in sickle cell teams improves sickle cell care.

|May 21, 2026
Clonal Hematopoiesis Rates in a Recurrent Venous Thrombosis Population: A Prospective Pilot Study.

|Jun 12, 2025
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML.

Joshua F Zeidner, Tara L Lin, Rina Li Welkie

|Mar 27, 2025
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.

Uma Borate, Kelly Pugh, Allyson Waller

Pageof 2

Frequent Collaborators

4 joint publications

Joshua F Zeidner

3 joint publications

Tara L Lin

3 joint publications

Brian J Druker

3 joint publications

Elie Traer